Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson announced today that it has received approval from the US Food and Drug Administration for its BD Max Vaginal Panel for the diagnosis of vaginitis and vaginosis in women who exhibit symptoms of vaginal infections. 

The assay runs on the BD Max System, which combines automated real-time PCR extraction, amplification, and detection on a single platform. It is designed to detect the pathogens responsible for bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.